SE8601940D0 - Preparation of fused proteins, antibodies and processes therefor - Google Patents

Preparation of fused proteins, antibodies and processes therefor

Info

Publication number
SE8601940D0
SE8601940D0 SE8601940A SE8601940A SE8601940D0 SE 8601940 D0 SE8601940 D0 SE 8601940D0 SE 8601940 A SE8601940 A SE 8601940A SE 8601940 A SE8601940 A SE 8601940A SE 8601940 D0 SE8601940 D0 SE 8601940D0
Authority
SE
Sweden
Prior art keywords
fused
antibodies
preparation
protein
fused proteins
Prior art date
Application number
SE8601940A
Other languages
English (en)
Swedish (sv)
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Priority to SE8601940A priority Critical patent/SE8601940D0/xx
Publication of SE8601940D0 publication Critical patent/SE8601940D0/xx
Priority to AU71568/87A priority patent/AU630070C/en
Priority to EP87850125A priority patent/EP0243333A3/en
Priority to DK203087A priority patent/DK203087A/da
Priority to JP62101103A priority patent/JPS62272989A/ja
Priority to KR870003986A priority patent/KR870010192A/ko
Priority to US08/130,430 priority patent/US5411732A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
SE8601940A 1986-04-25 1986-04-25 Preparation of fused proteins, antibodies and processes therefor SE8601940D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE8601940A SE8601940D0 (sv) 1986-04-25 1986-04-25 Preparation of fused proteins, antibodies and processes therefor
AU71568/87A AU630070C (en) 1986-04-25 1987-04-15 Preparation of fused proteins, antibodies and processes therefore
EP87850125A EP0243333A3 (en) 1986-04-25 1987-04-15 Preparation of fused proteins, antibodies and processes therefore
DK203087A DK203087A (da) 1986-04-25 1987-04-21 Fremgangsmaade til fremstilling af fusionsproteiner og anvendelse af det derved fremstillede fusionsprotein som vaccine
JP62101103A JPS62272989A (ja) 1986-04-25 1987-04-23 融合タンパク質、抗体およびこれらの製造方法
KR870003986A KR870010192A (ko) 1986-04-25 1987-04-25 융합단백질 및 항체의 제조방법
US08/130,430 US5411732A (en) 1986-04-25 1993-10-01 Preparation of fused proteins, antibodies and processes therefore

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8601940A SE8601940D0 (sv) 1986-04-25 1986-04-25 Preparation of fused proteins, antibodies and processes therefor

Publications (1)

Publication Number Publication Date
SE8601940D0 true SE8601940D0 (sv) 1986-04-25

Family

ID=20364358

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8601940A SE8601940D0 (sv) 1986-04-25 1986-04-25 Preparation of fused proteins, antibodies and processes therefor

Country Status (6)

Country Link
US (1) US5411732A (ko)
EP (1) EP0243333A3 (ko)
JP (1) JPS62272989A (ko)
KR (1) KR870010192A (ko)
DK (1) DK203087A (ko)
SE (1) SE8601940D0 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
US5976839A (en) * 1987-03-13 1999-11-02 Bioenterprises Pty Limited Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
WO1991000912A1 (en) * 1989-07-07 1991-01-24 Massachusetts Institute Of Technology Production and use of hybrid protease inhibitors
EP0580859A4 (en) * 1991-03-26 1994-09-14 Otsuka Pharma Co Ltd Anti-eda monoclonal antibody
JPH05339295A (ja) * 1991-12-05 1993-12-21 Agency Of Ind Science & Technol 抗体の作成方法
US6610838B1 (en) 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
JP2007110968A (ja) * 2005-10-20 2007-05-10 Matsumoto Sogo Kikaku Kk 微生物活性剤、環境浄化方法、および、環境浄化システム
WO2008086813A2 (en) * 2007-01-19 2008-07-24 Kobenhavns Universitet Peptides derived from proteins of the insulin super-family
JP5557254B2 (ja) 2009-02-10 2014-07-23 国立大学法人 琉球大学 薬物運搬体並びにこれを利用したアジュバントおよびワクチン
US20110136169A1 (en) * 2009-11-20 2011-06-09 Rutgers, The State University Of New Jersey Expression system compositions and methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
US4703004A (en) * 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
US4707358A (en) * 1984-01-30 1987-11-17 The University Of Chicago Vaccine against Epstein-Barr Virus
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
EP0177583A4 (en) * 1984-04-06 1988-06-08 Scripps Clinic Res PEPTIDE VACCINE OR DIAGNOSTIC, AND POLYPEPTIDE FOR USE THEREOF.
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
SE8505921D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab A method to export gene products to the growth medium of gram negative bacteria
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering

Also Published As

Publication number Publication date
DK203087D0 (da) 1987-04-21
AU7156887A (en) 1987-10-29
JPS62272989A (ja) 1987-11-27
KR870010192A (ko) 1987-11-30
EP0243333A3 (en) 1988-06-15
EP0243333A2 (en) 1987-10-28
DK203087A (da) 1987-10-26
AU630070B2 (en) 1992-10-22
US5411732A (en) 1995-05-02

Similar Documents

Publication Publication Date Title
IL89011A0 (en) Receptor protein,dna sequence coding therefor and process for the preparation thereof
ES8305419A1 (es) Un peptido
NO863000D0 (no) Fusjonsproteiner og fremgangsmaate til fremstilling derav.
CZ738982A3 (en) Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use
FI93310C (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
DK645887A (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
SE8601940D0 (sv) Preparation of fused proteins, antibodies and processes therefor
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
ATE126701T1 (de) Äusseres membranprotein p1 und peptide von haemophilus influenzae typ b.
IL82720A0 (en) Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions
GR3003754T3 (ko)
ES2083352T3 (es) Produccion de proteinas activas que contienen residuos de cisteina.
NO178504C (no) Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi